Showing posts with label Biodental Remin. Show all posts
Showing posts with label Biodental Remin. Show all posts

Thursday, April 7, 2011

Biodental Remin's joint venture with Red Seal Natural Health

Australian-based technology start-up company Biodental Remin Ltd today announced it is entering into a Joint Venture partnership with Red Seal Natural Health of New Zealand, to manufacture and distribute dental and oral hygiene products using Biodental’s tooth remineralising technology in Australia and New Zealand.

Red Seal was the recipient of an early sample of the remineralising powder which was used to make a trial batch of 5 % active toothpaste. The reaction to the trial material from their dental and consumer evaluation panels was extremely positive.

“Our trial results were very positive, so much so that some evaluators were even asking for more material after the trials, because they found it so effective. This is one of the most exciting developments in dentistry and oral hygiene that we have ever encountered. We are very happy indeed to be forming a partnership with Biodental Remin as we see oral healthcare products as a focus for our future growth” Mr Rolf Hilke, Managing Director, Red Seal

As well as taking an equity position in Biodental Remin, Red Seal will be making a major investment to ensure the success of the Joint Venture. They will fund the manufacturing and packaging of dental & oral hygiene products using Biodental Remin’s technology and then profit-share with Biodental in a way that is heavily weighted in favour of BDR in the early stages. The Directors of Biodental Remin believe that Red Seal’s commitment to the joint program underpins BDR’s goals and is worth an estimated $100,000 to BDR over the short term.

The joint venture agreement provides BDR with a means for early stage low cost manufacturing and sales which will expand as BDR’s production of anticay increases. An increase in production will allow entry to Red Seal’s established markets for broad market consumables.

The first products to emerge from the joint venture will be targeted to the dental professionals and will be on sale within 2-3 months. Entry to Red Seal’s established distribution network for broad market consumables will follow as BDR’s production of Anticay is expanded.

For further information contact Biodental Remin Ltd:

Tim Erskine Smith,

info@biodentalremin.com

+61 2 6568 4420

Monday, May 24, 2010

Biodental Remin Announces Indian Group Pharmaceuticals Partnership

MEDIA RELEASE

25 May, 2010

Biodental Remin Announces Indian Group Pharmaceuticals Partnership

Biodental Remin Limited announces it has agreed to the first stages of a partnership with Group Pharmaceuticals Ltd of Bangalore, India.

Group Pharma is a medium-sized Indian pharmaceutical company that specialises in the manufacture and distribution of products for dental and oral care. They currently have more than 250 sales representatives directly meeting more than 60,000 dentists each month; their oral hygiene products are sold through some 85,000 retail outlets. They already manufacture products for some well-known dental and oral hygiene companies.

Biodental Remin has the technical know how to manufacture Enamelguard - a material that is tasteless and water soluble, with wide application in oral hygiene, confectionary, beverage, nutraceutical and pet care industries. Biodental also intend using Enamelguard in their own line of dental professional and oral health care products.

Group Pharma intends using Enamelguard in the manufacture and sale within India of professional dental and consumer-level oral-hygiene products for remineralising teeth.

Group Pharma can also assist in facilitating low cost clinical studies and research.

Biodental Remin will also be able to exclusively access Group Pharma’s low-cost production centres for the manufacture of BDR’s mass-market products to be sold elsewhere.

Tim Erskine-Smith, Managing Director of Biodental Remin, said that he welcomed the partnership with Group Pharma and that he was delighted to have such strong support from a large and influential pharmaceutical company at this early stage of the company’s development.



For more information contact:
Kate Ingham
Alchemy Equities
Ph. +1300 308 882
Fx. +61 2 9994 8008
www.biodentalremin.com
www.assob.com.au/bdr